Semaglutide Green Tops(OZEMPIC)

$75.00

1 vial x 5mg

  • At first, 0.25 milligrams (mg) injected under the skin once a week for 4 weeks. Your doctor may increase your dose every 4 weeks. However the dose is usually not more than 2.4 mg once a week.
Category:

Description

Semaglutide belongs to a class of medications known as glucagon-like peptide-1 (GLP-1) receptor agonists. It mimics the GLP-1 hormone that is released in the gastrointestinal tract in response to eating. One role of GLP-1 is to prompt the body to produce more insulin, which reduces blood glucose (sugar).

 

Dosing

The dose of this medicine will be different for different patients. Follow your doctor’s orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.

The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.

  • For type 2 diabetes and lowering the risk of heart attack or stroke:
    • For injection dosage form:
      • Adults—At first, 0.25 milligrams (mg) injected under the skin once a week for 4 weeks. Your doctor may increase your dose as needed. However, the dose is usually not more than 2 mg once a week.
      • Children—Use and dose must be determined by your doctor.
  • For weight management:
    • For injection dosage form :
      • Adults and children 12 years of age and older—At first, 0.25 milligrams (mg) injected under the skin once a week for 4 weeks. Your doctor may increase your dose every 4 weeks. However the dose is usually not more than 2.4 mg once a week.
      • Children younger than 12 years of age—Use and dose must be determined by your doctor.

Reviews

There are no reviews yet.

Be the first to review “Semaglutide Green Tops(OZEMPIC)”

Your email address will not be published. Required fields are marked *